Clinical Trials Directory

Trials / Unknown

UnknownNCT05085223

Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients

Development of Hypernatremia in Critically Ill Patients: Prospective Analysis

Status
Unknown
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Catharina Ziekenhuis Eindhoven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypernatremia is frequently encountered in patients admitted to the Intensive Care Unit (ICU) and associated with increased mortality and length of stay. Previous studies focused on predictors in the development and recovery of hypernatremia by including amount and types of administered medication, fluid balance, laboratory results and changes in vital signs. However, data of larger populations or data on infusion rates, fluid and sodium balance or renal replacement therapy is lacking. The predecessor of this study was the HYPNIC trial which found that increased sodium load en decreased sodium excretion preceded hypernatremia development, but was lacking information on the first 48 hours, fluid balances were manually collected before a new data collection system was introduced and was suffering from substantial amounts of missing data and small population for trend analysis. This study aims to provide better insight in the development and recovery of hypernatremia while paying attention to the limitations from the HYPNIC trial.

Conditions

Interventions

TypeNameDescription
OTHERDaily urine collection for biochemical analysisFor every patient in ICU, a daily morning urine sample will be collected from the already collected urine via catheter.
OTHERSubanalysis for comparison of 24hour urine collection versus spot-check measurementsFor a subgroup of 30 sedated patients, 24 hour urine collection will be collected. In addition, every 2 hours a 10ml urine sample will be collected.

Timeline

Start date
2021-10-01
Primary completion
2022-10-31
Completion
2022-11-30
First posted
2021-10-20
Last updated
2021-10-27

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05085223. Inclusion in this directory is not an endorsement.